Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance.
Publication
, Journal Article
Califf, RM
Published in: JAMA
February 21, 2017
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 21, 2017
Volume
317
Issue
7
Start / End Page
693 / 694
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Uncertainty
- Risk Assessment
- Humans
- General & Internal Medicine
- Drug Approval
- Device Approval
- Decision Making
- Clinical Trials as Topic
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (2017). Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance. JAMA, 317(7), 693–694. https://doi.org/10.1001/jama.2017.0410
Califf, Robert M. “Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance.” JAMA 317, no. 7 (February 21, 2017): 693–94. https://doi.org/10.1001/jama.2017.0410.
Califf RM. Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance. JAMA. 2017 Feb 21;317(7):693–4.
Califf, Robert M. “Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance.” JAMA, vol. 317, no. 7, Feb. 2017, pp. 693–94. Pubmed, doi:10.1001/jama.2017.0410.
Califf RM. Benefit-Risk Assessments at the US Food and Drug Administration: Finding the Balance. JAMA. 2017 Feb 21;317(7):693–694.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 21, 2017
Volume
317
Issue
7
Start / End Page
693 / 694
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Uncertainty
- Risk Assessment
- Humans
- General & Internal Medicine
- Drug Approval
- Device Approval
- Decision Making
- Clinical Trials as Topic